Align Technology, Inc. (ALGN) Institutional Ownership & Insider Trading

671 institutions reported holding Align Technology, Inc. shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 1 insider trades on Form 4 since 2025-10-01.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

ALGNAlign Technology, Inc.Follow ALGN — free

Medical Instruments & Supplies · Healthcare

—

Price chart with a free account

Market cap: 11.0B
P/E TTM: 26.9
Dividend yield: —
52-week: —
Next earnings: 28 Oct, in 4 days

Institutions · all 13F filers

quarter to 30 Jun 2026 · filers in both quarters

671 institutions held —% of the shares. Across filers that reported both quarters, shares held changed +3.9%.

Largest moves, shares (millions)

Institutional flow by quarter

net shares added or trimmed, millions · filers in both quarters

Quarter	Holders	Shares held, M	Change	Increased	New	Decreased	Closed
Jun 26	671	73	+3.9%	192	52	238	70
Mar 26	683	69	+5.3%	222	97	188	69
Dec 25	653	67	-6.9%	205	90	228	101
Sep 25	644	71	+7.8%	226	79	207	111
Jun 25	687	67	+0.9%	222	82	226	76
Mar 25	667	65	+2.1%	243	69	207	98
Dec 24	696	65	-1.1%	190	64	255	91
Sep 24	706	64	-0.3%	227	52	241	88

Align Technology, Inc. — questions

Who owns Align Technology, Inc. stock?: 671 institutions reported Align Technology, Inc. shares in 13F filings for the quarter ended 2026-06-30. The largest: BlackRock, Inc. (6.2%), VANGUARD CAPITAL MANAGEMENT LLC (6.2%), FMR LLC (5.7%).
Are Align Technology, Inc. insiders buying or selling?: 1 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.

Every figure on this page comes from Align Technology, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.